Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Germany Gets Creative with Payer-Pharmaco Contracts

This article was originally published in The Pink Sheet Daily

Executive Summary

Rebate contracts between German insurance funds and generic firms have become widespread since, but the funds are increasingly negotiating deals on innovator drugs as well.

You may also be interested in...



Emerging Markets, Biosimilars May Enhance Suitors' Interest In ratiopharm

More than a year after being put up for sale, German generics firm ratiopharm is now said to have three serious suitors: generics giant Teva, Iceland's Actavis and Pfizer

Emerging Markets, Biosimilars May Enhance Suitors' Interest In ratiopharm

More than a year after being put up for sale, German generics firm ratiopharm is now said to have three serious suitors: generics giant Teva, Iceland's Actavis and Pfizer

Pay-For-Performance Hits France As Part Of Cost-Cutting Measures

Facing a €11 billion ($16 billion) deficit in 2009 in its state-funded health service - which is forecast to reach a whopping €17 billion next year - French ministers announced in late September a series of measures to help curb spending growth

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS069911

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel